BioCentury
ARTICLE | Financial News

Bellus Health raises C$20M in follow-on

December 15, 2017 9:36 PM UTC

On Dec. 12, Bellus Health Inc. (TSX:BLU) raised C$20 million ($15.6 million) through the sale of 52.6 million shares at C$0.38 in a follow-on. The price values the company at C$45.4 million ($35.4 million). Bloom Burton, Cormark and Mackie Research Capital were agents.

In 3Q18, Bellus plans to begin a Phase I trial of BLU-5937 to treat chronic cough...